CCR5 and neoplasm: Of interest is the fact that in contrast to these culture experiments, maraviroc has led to significant inhibition of tumor metastasis in animal studies (49, 51), possibly reflecting the ability of CCR5 to promote breast malignancy by additional pro-tumorigenic properties, such as those that depend on cellular migration.